Last reviewed · How we verify
Veripaque (OXYPHENISATINE)
Veripaque (generic name: OXYPHENISATINE) is a oxyphenisatine drug. It is currently FDA-approved for Constipation.
Veripaque, also known as oxypHENISATIN, is a small molecule medication. Its exact clinical uses are not specified in the provided facts, but it has been identified by various synonyms.
At a glance
| Generic name | OXYPHENISATINE |
|---|---|
| Drug class | oxyphenisatine |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Constipation
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Veripaque CI brief — competitive landscape report
- Veripaque updates RSS · CI watch RSS
Frequently asked questions about Veripaque
What is Veripaque?
Veripaque (OXYPHENISATINE) is a oxyphenisatine drug, indicated for Constipation.
What is Veripaque used for?
Veripaque is indicated for Constipation.
What is the generic name of Veripaque?
OXYPHENISATINE is the generic (nonproprietary) name of Veripaque.
What drug class is Veripaque in?
Veripaque belongs to the oxyphenisatine class. See all oxyphenisatine drugs at /class/oxyphenisatine.
What development phase is Veripaque in?
Veripaque is FDA-approved (marketed).
Related
- Drug class: All oxyphenisatine drugs
- Therapeutic area: All drugs in Other
- Indication: Drugs for Constipation
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing